![]() Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. | AnaptysBio AnaptysBio is a biotechnology company developing immunology therapeutic product candidates. | |||
Founding Date | Founding Date 2000 | Founding Date 2003 | Founding Date 2005 | Founding Date 1978 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Waltham, US HQ Lawrence, US | Locations San Diego, US HQ San Diego, US | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more |
Employees | Employees 82517% decrease | Employees 35037% increase | Employees 898% decrease | Employees 16,5612% increase |
Valuation ($) | Valuation ($) 648.3 m | Valuation ($) 2.2 b | Valuation ($) 930.2 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) $163.4m (FY, 2023) | Revenue (est.) $234.6m (FY, 2025) | Revenue (est.) ₹167.8b (FY, 2026) |
Cost of goods | Cost of goods €9.7m (FY, 2024) | Cost of goods $3.7m (FY, 2023) | Cost of goods N/A | Cost of goods ₹56.9b (FY, 2026) |
Gross profit | Gross profit €534.4m (FY, 2024) | Gross profit $159.6m (FY, 2023) | Gross profit N/A | Gross profit ₹115.8b (FY, 2026) |
Net income | Net income €162.2m (FY, 2024) | Net income ($194.9m) (FY, 2023) | Net income N/A | Net income ₹3.7b (FY, 2026) |
Operating ⚠ | ||||
Patent Applications | Patent Applications 500 (Mar, 2020) | Patent Applications 49 (Aug, 2017) | Patent Applications N/A | Patent Applications N/A |
Funding | ||||
Total funding raised | Total funding raised $ 1.1b | Total funding raised $ 714m | Total funding raised $ 83.9m | Total funding raised N/A |

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
View companyAnaptysBio is a biotechnology company developing immunology therapeutic product candidates.
View company
Biocon is a company that develops and manufactures biopharmaceutical products.
View company